- Home
- FLXS vs SLS Comparison
FLXS vs SLS Comparison
Compare FLXS & SLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLXS
- SLS
- Stock Information
- Founded
- FLXS 2001
- SLS 2012
- Country
- FLXS United States
- SLS United States
- Employees
- FLXS N/A
- SLS N/A
- Industry
- FLXS Home Furnishings
- SLS Biotechnology: Pharmaceutical Preparations
- Sector
- FLXS Consumer Discretionary
- SLS Health Care
- Exchange
- FLXS Nasdaq
- SLS Nasdaq
- Market Cap
- FLXS 184.8M
- SLS 208.0M
- IPO Year
- FLXS N/A
- SLS N/A
- Fundamental
- Price
- FLXS $39.36
- SLS $1.45
- Analyst Decision
- FLXS
- SLS Strong Buy
- Analyst Count
- FLXS 0
- SLS 1
- Target Price
- FLXS N/A
- SLS $7.00
- AVG Volume (30 Days)
- FLXS 35.3K
- SLS 3.5M
- Earning Date
- FLXS 10-20-2025
- SLS 11-12-2025
- Dividend Yield
- FLXS 2.04%
- SLS N/A
- EPS Growth
- FLXS 64.53
- SLS N/A
- EPS
- FLXS 4.11
- SLS N/A
- Revenue
- FLXS $447,505,000.00
- SLS N/A
- Revenue This Year
- FLXS $3.93
- SLS N/A
- Revenue Next Year
- FLXS $4.20
- SLS N/A
- P/E Ratio
- FLXS $9.54
- SLS N/A
- Revenue Growth
- FLXS 6.00
- SLS N/A
- 52 Week Low
- FLXS $29.38
- SLS $0.77
- 52 Week High
- FLXS $65.87
- SLS $2.48
- Technical
- Relative Strength Index (RSI)
- FLXS 61.54
- SLS 39.80
- Support Level
- FLXS $34.59
- SLS $1.45
- Resistance Level
- FLXS $40.28
- SLS $1.58
- Average True Range (ATR)
- FLXS 1.21
- SLS 0.11
- MACD
- FLXS 0.82
- SLS -0.00
- Stochastic Oscillator
- FLXS 83.74
- SLS 25.00
About FLXS Flexsteel Industries Inc.
Flexsteel Industries Inc is a United States-based company that manufactures, imports, and markets residential upholstered wooden furniture products. Its product offerings include sofas, loveseats, chairs, rockers, desks, tables, convertible bedding units, and bedroom furniture. The company's products are intended for use in home, office, hotel, healthcare, and other contract applications. A featured component in the company's upholstered furniture is the durable Blue Steel Spring. It operates in the business segment of Furniture products. The company's furniture products business involves the distribution of manufactured and imported products for residential markets.
About SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.